Company name ACADIA Pharmaceuticals Inc.
Stock symbol ACAD
Status Under Investigation

NEW YORK, July 9, 2018 – Bragar Eagel & Squire, P.C. is investigating potential claims against ACADIA Pharmaceuticals Inc. (NYSE: ACAD).  Our investigation concerns whether ACADIA violated the federal securities laws and/or engaged in other unlawful business practices.

On April 9, 2018, CNN reported that Nuplazid, Acadia’s Parkinson’s disease psychosis treatment, has been associated with more than 700 deaths, and that adverse event reports concerning the drug link it to additional life-threatening incidents, falls, insomnia, nausea, and fatigue.  On this news, Acadia’s share price fell $5.03, or 23.36%, to close at $16.50 on April 9, 2018.

On July 9, 2018, a report was published by The Southern Investigative Reporting Foundation alleging that ACADIA’s “pursuit of regulatory approval is best described as ‘loophole-centric’.”

If you purchased or otherwise acquired ACADIA shares and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.

First name*

Last name*

City, state, ZIP code

Email address*

Daytime phone

Evening phone

Purchase Date

No. of Shares

Purchase Price

Purchase Date

No. of Shares

Purchase Price

Join action?

Call to provide more information: Tel: (212) 308-4648

Please list below any additional transactions in this security:

Additional comments

The submission of this form does not create an attorney-client relationship, nor any obligation on the part of Bragar Eagel & Squire, P.C., or you to file a legal action. Any information you submit will be maintained as confidential. If Bragar Eagel & Squire, P.C., in its sole discretion, believes that you might be an appropriate class representative, Bragar Eagel & Squire, P.C., will contact you to discuss the matter and to determine whether to establish an attorney client relationship.